Evaluating Lumbar Disc Degeneration by MRI Quantitative Metabolic Indicators: The Perspective of Factor Analysis

Gene remedy is a new tool used in combating different conditions. It began to be intensively used in exploration systems in 1989 and important advances have been made in this remedy since also. The maturity of gene remedy clinical trials are concentrated on cancer and so it was no concurrence that the first marketable gene treatment in 2003 was for a neoplasia. noway the less, some inimical events have been observed in the use of this remedy performing in its strict surveillance and in the creation of creating safer remedial rules. presently there are a wide variety of gene remedy proffers involving a large number of antitumor molecular mechanisms that will possibly pave the way for largely effective treatment options. Despite the significant advances that have been made in gene remedy in the fight against cancer, its effectiveness, safety and marketable vacuity are still limited. These limitations are anticipated to gradationally be over come.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-15
DOI
https://doi.org/10.5281/zenodo.14485746
Primary Topic
Spine and Intervertebral Disc Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluating Lumbar Disc Degeneration by MRI Quantitative Metabolic Indicators: The Perspective of Factor Analysis

Zenodo (CERN European Organization for Nuclear Research)
Spine and Intervertebral Disc Pathology
article

Evaluating Lumbar Disc Degeneration by MRI Quantitative Metabolic Indicators: The Perspective of Factor Analysis

article en

Abstract

Gene remedy is a new tool used in combating different conditions. It began to be intensively used in exploration systems in 1989 and important advances have been made in this remedy since also. The maturity of gene remedy clinical trials are concentrated on cancer and so it was no concurrence that the first marketable gene treatment in 2003 was for a neoplasia. noway the less, some inimical events have been observed in the use of this remedy performing in its strict surveillance and in the creation of creating safer remedial rules. presently there are a wide variety of gene remedy proffers involving a large number of antitumor molecular mechanisms that will possibly pave the way for largely effective treatment options. Despite the significant advances that have been made in gene remedy in the fight against cancer, its effectiveness, safety and marketable vacuity are still limited. These limitations are anticipated to gradationally be over come.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 51%
Spine and Intervertebral Disc Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.